Article
Selective activation of endothelial cells by the antioxidant pyrrolidine dithiocarbamate: involvement of C-jun N-terminal kinase and AP-1 activation.
Endothelium : journal of endothelial cell research - 1 Jan 2000
Liao H L, Zhu Y, Wang N, Verna L, Stemerman M B
Abstract excerpt
The antioxidant agent pyrrolidine dithiocarbamate (PDTC) has been shown to protect endothelial cells (EC) from pro-inflammatory-induced and pro-oxidant-induced NF-kappaB activation. It also perturbs EC by altering activator protein-1 (AP-1) status and inducing ICAM-1. Experiments were performed to investigate the upstream mechanism by which PDTC produces these effects. We have demonstrated that PDTC not only...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
